How AI is helping solve the labor issue in treating rare diseases

AI-powered biotech startups are leveraging automation, data analytics, and gene editing to address critical staffing shortages in rare disease treatment and drug research. Presented at Web Summit Qatar, these innovations demonstrate how artificial intelligence can bridge the personnel gap in pharmaceutical development, enabling faster drug discovery and more accessible treatments for rare diseases despite limited human resources.